dihexa clinical trial human studies trials Dihexa Dihexa (PNB-0408) — Dosing, Side

H., Robinson, P

With these capabilities, BPC 157 therapy can recover glaucomatous rats, normalize intraocular pressure, maintain retinal integrity, recover pupil function, recover retinal ischemia, and corneal injuries (i.e., maintained transparency after complete corneal abrasion, corneal ulceration, and counteracted dry eye after lacrimal gland removal or corneal insensitivity)

It must be determined that it meets at least two of the following three criteria: It has the potential to enhance or enhances sport performance It represents an actual or potential health risk to the athletes It violates the spirit of sport WADA also published: The 2025 Monitoring Program, which includes substances that are not on the List , but that WADA wishes to monitor in order to detect potential patterns of misuse in sport

The flourishing and use of various innovations to achieve their goals

Annu Rev Med